May 14, 2012
OxySure (OXYS) Expands Production Capacity with New UV-Curing Conveyor System
OxySure Systems Inc. (OTCBB: OXYS), a medical technology company focused on the design, manufacture and distribution of specialty medical and respiratory solutions, similar to companies St. Jude Medical, Inc. (NYSE: STJ), recently announced that it purchased a new ultra violet curing conveyor system from Textron/Bell Helicopter (NYSE: TXT).
The new conveyor system will be incorporated into the company’s production line in the early part of the fourth quarter 2012 and eliminate 10-12 minutes of production cycle time. Investors are hoping that the improved efficiency will help drive revenues higher as demand for the company’s products pick up over the coming quarters.
OxySure(R) Systems, Inc. (OXYS) (“OxySure” or the “Company”), the pioneering manufacturer of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced the Company has expanded its production capability with the acquisition of an ultra violet curing conveyor system from Textron/Bell Helicopter.
Speaking from the annual Emergency Cardiovascular Care Update 2012 (ECCU 2012) Conference in Orlando, Florida where OxySure is an exhibitor Julian Ross, CEO of OxySure stated: “Our goal is to constantly improve our production process and reduce production cycle time. This UV-curing conveyor system should eliminate approximately ten to twelve minutes of production cycle time for us, and should improve our production efficiency significantly. We are pleased about that.”
According to the system manufacturer this widecure system offers fast, consistent curing of large parts, and the conveyor runs from 4 to 50 feet per minute. OxySure acquired the UV-curing system for cash, and took delivery on Monday, September 10, 2012. The Company plans to incorporate the system into its production line in the early part of the fourth quarter of 2012.
About OxySure Systems, Inc.
OxySure Systems, Inc. is a Frisco, Texas-based medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure’s products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other “Immediately Dangerous to Life or Health” (IDLH) environments. www.OxySure.com
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company’s expectations with regard to the future impact on the Company’s results from new products in development, may be deemed to be forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.
Please read our Full Disclaimer pertaining to this article.